Encephalitis virus is a mosquito-borne Flavivirus and is transmitted via an enzootic cycle from mosquitoes to amplifying vertebrate hosts such as pigs and wading birds.
It can easily be prevented using vaccines. It is the most common cause of encephalitis in Asia-Pacific. Encephalitis virus can easily be transmitted to humans through an infected mosquito bite and occurs primarily in rural agricultural areas.

The global Encephalitis Vaccine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Encephalitis Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Encephalitis Vaccine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Encephalitis Vaccine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Encephalitis Vaccine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Liaoning Chengda
Wuhan Institute of Biological
Valneva
Tiantan Biological Products
Sanofi Pasteur
Chengdu Institute of Biological Products
GlaxoSmithKline
Lanzhou Institute of Biological Products
Zhejiang Tianyuan Bio-Pharmaceutical
Biken

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
By strain
Nakayama
Beijing
P-3
SA 14-14-2
By type
Mouse Brain-Derived, Inactivated Vaccine
Cell Culture-Derived, Inactivated Vaccine
Cell Culture-Derived, Live Attenuated Vaccine

Segment by Application
Child
Adult